Evidence map›Paper›PMID 19812684›Full record

ArticlePloS one2009

Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.

Jill Koshiol, Melissa Rotunno, Dario Consonni, Angela Cecilia Pesatori, Sara De Matteis, Alisa M Goldstein, Anil K Chaturvedi, Sholom Wacholder, Maria Teresa Landi, Jay H Lubin and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02611570 (Low Dose Computed Tomography Screening Study in Non-smokers with Risk Factors for Lung Cancer in Taiwan), which is not on this map. Cited by 83 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 8 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02611570 active not recruitingnot on this mapstarted 2014, after this paper: background citation

Low Dose Computed Tomography Screening Study in Non-smokers with Risk Factors for Lung Cancer in Taiwan

TypeobservationalSponsorAcademia Sinica, TaiwanRan2014 to 2028Enrolled12,000ConditionsLung CancerArmsLDCT
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 8 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2020
    Pooled it
  2. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Lung cancer screening.Journal of the National Comprehensive Cancer Network : JNCCN · 2012
    Guideline
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011
    Trial
  13. Article
  14. Article
  15. Identifying risk factors for adverse lung health outcomes among rural Appalachian women.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jill KoshiolDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America. koshiolj@mail.nih.gov
Melissa Rotunno
Dario Consonni
Angela Cecilia Pesatori
Sara De Matteis
Alisa M Goldstein
Anil K Chaturvedi
Sholom Wacholder
Maria Teresa Landi
Jay H Lubin
Neil E Caporaso
National Institutes of Health · USNational Cancer Institute · USUniversity of Milan · ITOspedale Maggiore · IT

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) has been consistently associated with increased risk of lung cancer. However, previous studies have had limited ability to determine whether the association is due to smoking. METHODOLOGY/PRINCIPAL

findingsThe Environment And Genetics in Lung cancer Etiology (EAGLE) population-based case-control study recruited 2100 cases and 2120 controls, of whom 1934 cases and 2108 controls reported about diagnosis of chronic bronchitis, emphysema, COPD (chronic bronchitis and/or emphysema), or asthma more than 1 year before enrollment. We estimated odds ratios (OR) and 95% confidence intervals (CI) using logistic regression. After adjustment for smoking, other previous lung diseases, and study design variables, lung cancer risk was elevated among individuals with a history of chronic bronchitis (OR = 2.0, 95% CI = 1.5-2.5), emphysema (OR = 1.9, 95% CI = 1.4-2.8), or COPD (OR = 2.5, 95% CI = 2.0-3.1). Among current smokers, association between chronic bronchitis and lung cancer was strongest among lighter smokers. Asthma was associated with a decreased risk of lung cancer in males (OR = 0.48, 95% CI = 0.30-0.78). CONCLUSIONS/SIGNIFICANCE: These results suggest that the associations of personal history of chronic bronchitis, emphysema, and COPD with increased risk of lung cancer are not entirely due to smoking. Inflammatory processes may both contribute to COPD and be important for lung carcinogenesis.

Indexed as

AdultAgedAsthmaBronchitis, ChronicCase-Control StudiesEmphysemaFemaleHumansLung NeoplasmsMaleMiddle AgedOdds RatioPulmonary Disease, Chronic ObstructiveRegression AnalysisRisk

Identifiers

PMID19812684
PMCPMC2753644
OpenAlexW2119678176

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.